SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) — Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a clinical-stage, self-sustainable biotechnology company developing anti-fibrotic…
Cayuse announces implementations and expansions at The New School, Central State University, Clark Atlanta University, and Colorado Mesa University Portland,…